Annual EBITDA
-$255.18 M
-$33.30 M-15.01%
31 December 2023
Summary:
IGM Biosciences annual earnings before interest, taxes, depreciation & amortization is currently -$255.18 million, with the most recent change of -$33.30 million (-15.01%) on 31 December 2023. During the last 3 years, it has fallen by -$172.93 million (-210.24%). IGMS annual EBITDA is now -2222.81% below its all-time high of -$10.99 million, reached on 31 December 2017.IGMS EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBITDA
-$62.08 M
-$13.00 M-26.48%
30 September 2024
Summary:
IGM Biosciences quarterly earnings before interest, taxes, depreciation & amortization is currently -$62.08 million, with the most recent change of -$13.00 million (-26.48%) on 30 September 2024. Over the past year, it has increased by +$2.42 million (+3.75%). IGMS quarterly EBITDA is now -858.91% below its all-time high of -$6.47 million, reached on 30 September 2018.IGMS Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBITDA
-$225.78 M
+$2.42 M+1.06%
30 September 2024
Summary:
IGM Biosciences TTM earnings before interest, taxes, depreciation & amortization is currently -$225.78 million, with the most recent change of +$2.42 million (+1.06%) on 30 September 2024. Over the past year, it has increased by +$20.83 million (+8.45%). IGMS TTM EBITDA is now -3387.47% below its all-time high of -$6.47 million, reached on 30 September 2018.IGMS TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -15.0% | +3.8% | +8.4% |
| 3 y3 years | -210.2% | -44.0% | -66.2% |
| 5 y5 years | -1033.5% | -490.3% | -508.5% |
IGMS EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -210.2% | at low | -44.0% | +6.0% | -66.2% | +11.5% |
| 5 y | 5 years | -1033.5% | at low | -490.3% | +6.0% | -508.5% | +11.5% |
| alltime | all time | -2222.8% | at low | -858.9% | +6.0% | -3387.5% | +11.5% |
IGM Biosciences EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$62.08 M(+26.5%) | -$225.78 M(-1.1%) |
| June 2024 | - | -$49.08 M(-5.0%) | -$228.20 M(-6.9%) |
| Mar 2024 | - | -$51.68 M(-17.9%) | -$245.15 M(-3.9%) |
| Dec 2023 | -$255.18 M(+15.0%) | -$62.94 M(-2.4%) | -$255.18 M(+3.5%) |
| Sept 2023 | - | -$64.50 M(-2.3%) | -$246.61 M(+2.3%) |
| June 2023 | - | -$66.03 M(+7.0%) | -$241.11 M(+3.5%) |
| Mar 2023 | - | -$61.71 M(+13.5%) | -$232.86 M(+4.9%) |
| Dec 2022 | -$221.88 M(+38.0%) | -$54.37 M(-7.9%) | -$221.88 M(+2.3%) |
| Sept 2022 | - | -$59.00 M(+2.1%) | -$216.89 M(+7.9%) |
| June 2022 | - | -$57.78 M(+13.9%) | -$200.99 M(+11.3%) |
| Mar 2022 | - | -$50.73 M(+2.7%) | -$180.54 M(+12.2%) |
| Dec 2021 | -$160.84 M | -$49.38 M(+14.6%) | -$160.84 M(+18.4%) |
| Sept 2021 | - | -$43.10 M(+15.5%) | -$135.89 M(+20.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$37.33 M(+20.3%) | -$113.10 M(+19.1%) |
| Mar 2021 | - | -$31.03 M(+27.0%) | -$94.94 M(+15.4%) |
| Dec 2020 | -$82.25 M(+87.4%) | -$24.43 M(+20.3%) | -$82.25 M(+11.8%) |
| Sept 2020 | - | -$20.31 M(+6.0%) | -$73.58 M(+15.4%) |
| June 2020 | - | -$19.16 M(+4.4%) | -$63.79 M(+16.0%) |
| Mar 2020 | - | -$18.35 M(+16.5%) | -$55.01 M(+25.3%) |
| Dec 2019 | -$43.90 M(+95.0%) | -$15.76 M(+49.8%) | -$43.90 M(+18.3%) |
| Sept 2019 | - | -$10.52 M(+1.3%) | -$37.10 M(+12.2%) |
| June 2019 | - | -$10.39 M(+43.4%) | -$33.06 M(+45.8%) |
| Mar 2019 | - | -$7.24 M(-19.2%) | -$22.68 M(+46.9%) |
| Dec 2018 | -$22.51 M(+104.9%) | -$8.96 M(+38.4%) | -$15.43 M(+138.4%) |
| Sept 2018 | - | -$6.47 M | -$6.47 M |
| Dec 2017 | -$10.99 M | - | - |
FAQ
- What is IGM Biosciences annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for IGM Biosciences?
- What is IGM Biosciences annual EBITDA year-on-year change?
- What is IGM Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
- What is the all time high quarterly EBITDA for IGM Biosciences?
- What is IGM Biosciences quarterly EBITDA year-on-year change?
- What is IGM Biosciences TTM earnings before interest, taxes, depreciation & amortization?
- What is the all time high TTM EBITDA for IGM Biosciences?
- What is IGM Biosciences TTM EBITDA year-on-year change?
What is IGM Biosciences annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of IGMS is -$255.18 M
What is the all time high annual EBITDA for IGM Biosciences?
IGM Biosciences all-time high annual earnings before interest, taxes, depreciation & amortization is -$10.99 M
What is IGM Biosciences annual EBITDA year-on-year change?
Over the past year, IGMS annual earnings before interest, taxes, depreciation & amortization has changed by -$33.30 M (-15.01%)
What is IGM Biosciences quarterly earnings before interest, taxes, depreciation & amortization?
The current quarterly EBITDA of IGMS is -$62.08 M
What is the all time high quarterly EBITDA for IGM Biosciences?
IGM Biosciences all-time high quarterly earnings before interest, taxes, depreciation & amortization is -$6.47 M
What is IGM Biosciences quarterly EBITDA year-on-year change?
Over the past year, IGMS quarterly earnings before interest, taxes, depreciation & amortization has changed by +$2.42 M (+3.75%)
What is IGM Biosciences TTM earnings before interest, taxes, depreciation & amortization?
The current TTM EBITDA of IGMS is -$225.78 M
What is the all time high TTM EBITDA for IGM Biosciences?
IGM Biosciences all-time high TTM earnings before interest, taxes, depreciation & amortization is -$6.47 M
What is IGM Biosciences TTM EBITDA year-on-year change?
Over the past year, IGMS TTM earnings before interest, taxes, depreciation & amortization has changed by +$20.83 M (+8.45%)